Explorer
Subject Expert Committee
India

Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12
India

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
India

Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
India

Coronavirus HIGHLIGHTS | Subject Expert Committee Recommends Sputnik Light One-Shot Vaccine: Report
Health

Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
Health
Omicron Scare: Subject Expert Committee To Hold Meeting Tomorrow Over Booster Doses
India

CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18
Health

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years
India

Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
Cities
India
Technology
India
Advertisement
Trending News
